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GENERAL INTRODUCTION 
Lowering the cost of downstream processing from large-scale fermentation 
is a major challenge in the production of recombinant proteins for industrial and 
pharmaceutical use. This study addresses the development of an inexpensive 
recovery and purification system for genetically engineered fusion proteins that 
utilizes native (raw) starch as an alternative to high-cost affinity adsorbents. 
Fusion proteins, made by utilizing recombinant DNA technology, are fast 
becoming very popular for purification of target proteins from a complex mixture 
of proteins. Among the many advantages that the use of fusion proteins have to 
offer over conventional purification techniques, the most important ones are the 
relative ease and the low cost of the process steps. Usually only a single step 
after the fermentation yields a highly pure and sometimes concentrated product. 
Genetically engineered polypeptide tags can be used to promote selective 
adsorption of recombinant proteins by biospecific interaction with a variety of 
ligands (Ford et al. 1991). Previous studies have indicated that of the multiple 
glucoamylase forms found from various sources, at least one may possess a 
starch-binding domain (SBD), separate and independent of the catalytic domain, 
that allows reversible binding of the enzyme to raw starch (Hayashida and Flor 
1982, Ueda and Saha 1982, Medda et al. 1982, Saha and Ueda 1983, Takahashi et al. 
1985, Tanaka et al. 1986, Hayashida et al. 1989a, Hayashida et al. 1989b, Dalmia 
and Nikolov 1991). Svensson et al. (1983) have determined the aminoacid 
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sequences of the A. niger glucoamylase forms and reported that GA-II is identical 
to residues 1 through 512 of the peptide chain of GA-I, which is 616 residues long. 
GA-n lacks the C-terminal 104 aminoacids present in GA-I. Since GA-II is unable 
to bind to raw starch, it was hypothesized that the starch-binding domain either 
lay within or overlapped the C-terminal 104 aminoacids of GA-I (Svensson et al. 
1983). Belshaw and Williamson (1990) purified a 145 aminoacid-long peptide 
from the C-terminal of Aspergillus GA-I, using limited proteolysis of a GA-I 
preparation, by subtilisin and found that the peptide independently bound to raw 
starch. We have studied the raw starch binding property of GA-I in some detail 
(Dalmia and Nikolov 1991). The results indicated a strong potential candidate for 
a 'purification tag' in the starch-binding domain of GA-I. Our studies address the 
interactions of a starch-binding domain (SBD) from glucoamylase-I (GA-I) of 
Aspergillus niger with raw starch and a possible application of the SBD as an 
affinity tail for a single-step recovery and purification of fusion proteins from 
crude cell extracts, using native starch granules as an adsorbent. Starch has 
several favorable qualities for this application: it is plentiful and inexpensive, 
stable, biodegradable, nontoxic, and easy to recover by sedimentation or 
centrifugation. 
Chen et al. (1991a and 1991b) made several hybrid proteins by fusing 
different length fragments from the C-terminal region of GA-I to the C-terminus 
of P-galactosidase (p-gal). The fusion proteins were found to be active in raw 
starch binding in addition to having enzymatic activity of P-gal. They also found 
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that among all the fusion proteins, the fusion protein containing a 119 aminoacid 
segment from GA-I had the highest affinity for raw starch. This fusion protein 
(BSB119) had a 30-fold higher affinity for raw starch compared to wild-type p-gal. 
BSB119 was used as a model system to study the adsorption and elution 
behavior of SBD from starch (Dalmia and Nikolov 1994a). The results showed 
that the SBD is an independent domain that is functional when attached to 
another protein and the fusion expressed in E. coli. The adsorbed fusion protein 
was purified by competitive elution with various oligosaccharides. SDS-PAGE 
gels and Western blots showed that the purity of the fusion protein eluted from 
starch was as good or better than that obtained by conventional affinity 
chromatography. 
To test the generality of the proposed fusion protein approach to protein 
purification, another fusion (GSB119) was constructed with the same 119 
aminoacid SBD and glutathione S-transferase (Dalmia and Nikolov 1994b). This 
fusion protein formed inclusion bodies when produced in £. coli. Several 
procedures to reduce inclusion body formation were examined. The fusion 
protein was tested for its starch-binding activity and found to bind starch very 
specifically resulting in a single-step purification from crude bacterial lysates. 
An important aspect of expressing recombinant proteins in E. coli is their 
degradation by host proteases. Proteolytic degradation was observed with both 
BSB119 and GSB119 fusion proteins. It was speculated that the degradation 
occurs because the SBD from a eukaryotic source (A. niger) is perceived as 
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'foreign' by the E. coli and hence is susceptible to degradation. 
Cyclodextrin glucanotransferase (CGTase) from Bacillus macerans also 
adsorbs to raw starch (Norberg and French 1950, Schwimmer 1953). Villette et al. 
(1992) reported that the starch-binding site is separate from the catalytic site and 
from the structural data of CGTase (Hofmarm et al. 1989, Klein and Schulz 1991) 
concluded that this starch-binding domain must be located in domain E. Domain 
E is about 60 % homologous to the SBD from GA-I (Svensson et al. 1989). To test 
whether domain E is separate and independent of the catalytic domain, a P-gal 
fusion protein with domain E from CGTase was constructed and produced in 
£. coli. This fusion protein (BDE109) bound to starch with almost the same 
affinity and specificity as the SBD of GA-I, confirming the independence of 
domain E in CGTase. 
An Explanation of the Dissertation Organization 
The dissertation is organized into five major sections. The first section is a 
general introduction to the research presented in the dissertation. The second 
section is a review of literature relevant to this work. The next three sections 
describe the experimental approach and the results obtained and are in a format 
suitable for publication in a scientific journal with each section containing a list of 
cited references at the end. The three papers are followed by general conclusions. 
The references cited in the general introduction, literature review and general 
conclusions follow the general conclusions. In paper HE, the purification of 
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wt-P-gal, BSB119 and BDE109 and the adsorption isotherm experiments for these 
three proteins were performed by Kai Schiitte. 
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LITERATURE REVIEW 
Fusion Protein Technology 
As a result of the successful development of genetic engineering over the 
past decade, a new technique for efficient and controlled production and 
purification of proteins has emerged, namely: fusion protein technology (Goeddel 
et al. 1979, Marston 1986, Sharma 1986, Sassenfeld 1990, Uhlén and Moks 1990, 
Hammond et al 1991, Sherwood 1991, Ford et al. 1991). A DNA fragment 
encoding an additional polypeptide is fused to either the 5' or the 3' end of the 
gene of interest. These gene fusions can be expressed in a variety of microbial 
hosts and the resulting fusion proteins can be purified by techniques that utilize 
the properties of the additional polypeptide 'tag'. Tags with a variety of 
characteristics have been used (Ford et al. 1991). An enzymic or chemical cleavage 
site between the target protein and the purification tag can be easily included to 
permit removal of the latter, thereby enabling production of the target protein in 
its native form (Sassenfeld 1990), 
Many eukaryotic polypeptides with potential clinical or industrial uses are 
limited in supply due to their low natural availability and are consequently very 
expensive. Genetic engineering gives us the ability to express eukaryotic genes in 
prokaryotes, thus enabling large-scale production of essential polypeptides at a 
relatively low cost. Insulin, a vital drug for the treatment of diabetes, was one of 
the first successful commercial product of this technology (Goeddel et al. 1979). 
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However, foreign proteins are often rapidly degraded by host proteases and gene 
fusions may sometimes overcome that difficulty by stabilizing the recombinant 
polypeptide (Marston 1986), thus providing a more abundant source of these 
polypeptides. In addition, the use of gene fusions for expression of recombinant 
proteins has several other advantages. The polypeptide tag provides the 
biochemical basis for efficient recovery and purification schemes. The fusion 
protein can be localized in different compartments of the host cell, e.g. periplasm, 
cell wall, cytoplasm, culture medium (by excretion), depending on the host/tag 
pair used. The tag may be left attached to the target polypeptide because in most 
cases it does not severely affect the properties/activity of its fusion partner. 
Nevertheless, in cases where the properties are affected adversely or when the 
final use of the target polypeptide is therapeutic/clinical, an enzymic or chemical 
cleavage site between the tag and the target polypeptide may be included to allow 
removal of the tail and recover the product in its native form (Sassenfeld 1990). 
There are possible disadvantages with the use of fusion tags. The presence 
of a N or C-terminal tag may sometimes severely affect the functionality of the 
target protein. Removal of the tag by enzymic or chemical means is often 
inefficient and in many cases lead to unauthentic and/or heterologous N-termini 
in the target protein after the cleavage reaction. The inefficient and unauthentic 
cleavage is perhaps the greatest single drawback of fusion protein technology. 
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Choice of purification tag 
Several factors need to be considered before choosing a purification tag (or 
tail) for a given application. In most cases, the purification tag should not affect 
the function of the target protein and should be easily removable from the 
purified fusion protein if necessary. The choice of host organism is also very 
critical. E. colt has been used extensively as the microbe of choice for fusion 
protein expression but suffers from a major disadvantage in forming insoluble 
aggregates or inclusion bodies (Marston 1986, Cousens et al. 1987) when 
heterologous proteins are produced. Most schemes using purification tags do not 
work under the denaturing conditions required for inclusion body solubilization. 
Refolding of denatured proteins is still not very well understood. Therefore it is 
imperative that the fusion protein be produced in sufficient quantities in a soluble 
form for this technique to be useful. Secretion of the fusion protein may prevent 
in vivo aggregation but is not always possible. Difficulties with efficient secretion 
and degradation by membrane-bound proteases and/or secreted proteases makes 
secretion less attractive. 
Proteolytic degradation 
Degradation of foreign proteins by host proteases is a major problem in the 
production of recombinant proteins in bacteria. Degradation leads to lower yields 
and complications in the recovery and purification steps. E. coli is known to 
possess at least 25 different proteolytic enzymes (Miller 1987). Several 
heterologous proteins are highly susceptible to proteolytic degradation in E. coli, 
for example, the half-life of preproinsulrn has been shown to be less than two 
minutes in the cytoplasm (Talmadge and Gilbert 1982). The proteolytic stability of 
foreign proteins vary greatly and the factors influencing it are not completely 
understood (Georgiou 1988). The reducing environment in the E. coli cell prevents 
the formation of essential disulfide bonds which might affect in vivo stability of a 
foreign protein. Culture conditions can affect the degree of proteolysis. Glucose 
and oxygen starvation result in increased proteolysis. Growth at sub-optimal 
temperatures is a simple and effective way of reducing degradation (Oka et al. 
1985) and may also increase the amount of soluble protein in cases where 
inclusion bodies are formed (Schein and Notebom 1989, next section). Fusion to a 
native E. coli protein can protect the target polypeptide from extensive 
degradation (Shen 1984, Germino and Bastia 1984, Silhavy and Beckwith 1986). 
The product can also be protected from degradation if it forms inclusion bodies 
(Cheng et al. 1981, Kitano et al. 1987). 
Inclusion body formation 
The formation of protein aggregates or inclusion bodies inside the cell is a 
very important aspect of recombinant protein technology. When examined under 
a phase-contrast microscope, the protein aggregates appear as dark refractile 
bodies (Georgiou 1988). These inclusion bodies consist mainly of the 
overproduced recombinant polypeptide and its non-reducible polymers, with a 
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small amount of impurities (Marston et al. 1984). The aggregated polypeptide is 
present in a partial or completely denatured state in the inclusion bodies. 
Inclusion bodies are very resistant to solubilization but the protein can be 
solubilized by strong dénaturants like 5 to 8 M urea or 6 M guanidine 
hydrochloride. The solubilized protein is fully denatured (unfolded) and reduced 
and must correctly refold and form the necessary disulfide bonds to yield a 
functional protein. Although in many cases, attempts at in vitro refolding have 
been highly successful, the factors influencing correct refolding are not completely 
understood. In most cases, experimental conditions for denaturation and 
refolding must be obtained empirically. However, some general guidelines are 
available (Jaenicke and Rudolph 1990, Marston and Hartley 1990). Small 
monomeric proteins tend to refold more easily than large, bulky, multimeric 
proteins. The number of correct disulfide bonds that need to be formed also 
strongly influences the final yield of the refolding step (Fischer et al. 1993). 
Inclusion body formation may be eliminated or reduced by changing a 
variety of factors. Culture conditions can be manipulated to give a higher amount 
of soluble product. Reducing the growth temperature after induction of the 
recombinant protein production can reduce or even eliminate protein aggregation 
(Schein and Notebom 1989). Use of rich culture media and alteration of the cell's 
osmotic pressure by including certain non-metabolizable sugars in the growth 
medium have led to reduction in inclusion body formation in some cases (Bowden 
and Georgiou 1988, Blackwell and Horgan 1991). Some genetic approaches have 
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also been successful. Strandberg and Enfors (1991) reported that changes in the 
aminoacid sequence in the linker region between the two parts of a fusion protein 
abolished inclusion body formation. As understanding of the molecular bases for 
inclusion bodies grows, newer and more effective methods to control their 
formation will become available. The role of foldases or chaperonins, proteins 
that 'assist' along the pathways to protein folding, is being studied (Ellis and 
Hemmingsen 1989). 
Fischer et al. (1993) published an excellent review summarizing the different 
experimental methods of isolation, denaturation, and subsequent refolding of 
eukaryotic proteins containing disulfide bonds, which were expressed in E. coli as 
inclusion bodies. The review discusses how some of the methods that were 
originally developed for studying the folding of naturally occurring proteins have 
been successfully adapted for reactivation of recombinant eukaryotic proteins. 
General Description of Enzymes Used in this Work 
This section briefly reviews some general characteristics of the four 
enzymes that are used in this study. 
Glucoamvlase-I 
Glucoamylase (1,4-a-D-glucan glucohydrolase, EC 3.2.1.3) is an exo-acting 
carbohydrase that cleaves glucose units consecutively from the non-reducing end 
of starch molecules. Glucoamylase is produced naturally by many molds and 
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yeasts (Saha and Zeikus 1989). Among the more common sources are Aspergillus, 
Rhizopus, and Endomyces species. Glucoamylase frequently occurs in multiple 
forms with one form predominantly active in raw starch adsorption and digestion 
(Hayashida and Flor 1982, Ueda and Saha 1982, Medda et al 1982, Saha and Ueda 
1983, Takahashi et al 1985, Tanaka et al 1986, Hayashida et al 1989a, Hayashida 
et al 1989b, Dalmia and Nikolov 1991). 
The molecular and biochemical characteristics of glucoamylase vary 
depending on its source. In most cases, glucoamylases are glycoproteins having 
about 5-20 % carbohydrate residues, composed mainly of marmose, glucose, 
galactose, and glucosamine (Saha and Zeikus 1989). These carbohydrate moieties 
play a role in the stability of the enzyme (Pazur et al 1987). Svensson et al (1983) 
have determined the aminoacid sequences of the Aspergillus niger glucoamylase 
forms and reported that GA-II is identical to residues 1 through 512 of the peptide 
chain of GA-I, which is 616 residues long. The active sites of both forms are 
identical in kinetic properties and subsite structure, therefore the C-terminal 104 
aminoacids present in GA-I but lacking in GA-II do not affect the functioning of 
the active site (Meagher et al 1988). Both GA-I and GA-II have similar activities 
towards soluble starch but only GA-I (the larger form) can bind and hydrolyze 
raw (insoluble) starch efficiently. The existence of a separate and independent 
starch-binding domain in GA-I was confirmed by Chen et al (1991a and 1991b) by 
fusing different length fragments from the C-terminus of GA-I to the C-terminus 
of p-galactosidase. Belshaw and Williamson (1990) also confirmed the same result 
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by isolating a 145 aminoacid-long peptide from the C-terminus of GA-I and 
reporting that it independently bound to raw starch. 
B-Galactosidase 
P-Galactosidase (P-gal) is a native E. coli enzyme that catalyzes the 
hydrolysis of lactose to glucose and galactose. P-Gal is a tetramer composed of 
four identical subunits, each with a molecular weight of 116 kDa (Fowler and 
Zabin 1970 and 1978). It has been extensively characterized and in addition 
several methods for its purification from E. coli have been reported. The most 
widely used purification procedure is that described by Steers et al. (1971). 
Although initially Steers' procedure was believed to be that of affinity 
chromatography of p-gal on a substrate (p-aminophenyl p-D-thiogalacto-
pyranoside) immobilized on agarose, it is now confirmed that the mechanism of 
purification is not truly biospecific affinity but some sort of hydrophobic 
interaction with the immobilized substrate (Scouten 1981). In any case, the 
procedure works well in purifying P-gal and is extensively used. 
Glutathione S-Transferase 
Glutathione S-transferases (GST, EC 2.5.1.18) are ubiquitous and belong to a 
family of multifunctional enzymes that play a physiological role in initiating the 
cellular detoxification of cytotoxic and genotoxic compounds (for reviews see 
Habig et al. 1974, Mannervik and Danielson 1988, Boyer 1988, Pickett and Lu 1989 
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and Coles and Ketterer 1990). These enzymes catalyze the reaction of such 
compounds with the -SH group of glutathione, neutralizing their electrophilic sites 
and making them more water-soluble (Habig et al. 1974). They have also been 
implicated in rendering cells and organisms resistant to electrophilic anticancer 
drugs, pesticides and herbicides (Hayes and Wolf 1988, Waxman 1990). Many 
mammalian GST isozymes have been purified by conventional methods as well as 
by affinity chromatography on immobilized glutathione (Habig et al 1974, 
Fjellstedt et al 1973, Clark et al 1977, Simons and Vander Jagt 1977, Marmervik 
1985) and their properties have been characterized in detail. Recently, Reinemer 
and coworkers (Reinemer et al 1991) described a three-dimensional structure of a 
class 7t glutathione S-transferase in complex with glutathione sulfonate at 2.3 Â 
resolution. The protein was found to be a dimer, composed of identical subunits. 
In attempting to identify parasite molecules that induce host-protective 
immunity in mice to infection with a parasitic helminth Schistosoma japonicum, 
Smith and coworkers isolated a cDNA clone corresponding to a 26 kDa adult 
worm antigen (Smith et al. 1986). The predicted aminoacid sequence showed close 
homology with published sequences of mammalian glutathione S-transferases. 
Evidence was presented that the antigen is a functional glutathione S-transferase. 
The cDNA construct for the enzyme was cloned into a bacterial expression system 
and enzymatically active protein was purified by affinity chromatography (Smith 
et al 1988). The GST was used as a purification tag to generate several different 
fusion proteins and the fusions purified by affinity chromatography on 
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immobilized glutathione (Smith and Johnson 1988). Plasmid expression vectors 
were constructed that direct the synthesis of polypeptides as C-terminal fusions 
with GST. The vectors were engineered with either a thrombin or a Factor X, 
cleavage site between the coding regions for GST and the target polypeptide. 
Following site-specific cleavage, the GST and any uncleaved fusion protein can be 
removed by readsorption to immobilized glutathione. The original vectors and 
several modified ones are available commercially from Pharmacia LKB 
(Piscataway, NJ). 
Cvclodextrin GlucanoTransferase 
Cyclodextrin glucanotransferases (CGTase, EC 2.4.1.19) are monomeric 
extracellular Bacillus enzymes that catalyze the degradation of starch to 
cyclodextrins and to transglycosylated linear chains by the following two reactions 
(Bender 1986): 
Gn ^ G(n.x) + cGx (cyclization, coupling: n > 8; 9 > x > 6) (1) 
Gn + Gm ^ G(n.x) + G(m+x) (disproportionation: n > 3, m > 1; x > 1) (2) 
where G^ and G^ are a(l->4)-glucopyranosyl chains of length n and m, cG^ are 
cyclodextrins of ring size x. 
CGTases are divided into a, P or y-cyclodextrin producers, depending 
upon the major type of cyclodextrin formed by them. There is strong sequence 
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and structural homology between CGTases and various amylases (MacGregor and 
Svensson 1989). The raw starch binding and degrading ability of both amylases 
and CGTases and the sequence homology between their C-terminal regions 
suggested that CGTases possess a raw-starch binding site separate from the active 
site, similar to many amylases and glucoamylases (Villette et al 1992, Svensson 
et al. 1989). The CGTase from Bacillus circulans has been crystallized and its three-
dimensional structure described at 2.0 Â resolution (Klein and Schulz 1991). The 
overall structure was divided into 5 domains named A, B, C, D and E, domain E 
being the C-terminal region and believed to contain a raw starch binding site. 
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PAPER I: CHARACTERIZATION OF A p-GALACTOSIDASE FUSION 
PROTEIN CONTAINING THE STARCH-BINDING DOMAIN OF 
ASPERGILLUS GLUCOAMYLASE 
A paper published in Enzyme and Microbial Technology^ 
Bipin K. Dalmia^ and Zivko L. Nikolov'^'^ 
® Reprinted with permission from Enzyme and Microbial Tecimology 1994, 16, 18-23. 
Copyright © 1994 Enzyme and Microbial Technology. 
'' Department of Chemical Engineering, Iowa State University, Ames, Iowa, USA. 
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ABSTRACT 
Granular starch was used as a biospecific adsorbent to investigate the 
possible application of the starch-binding domain (SBD) as an affinity tail for one-
step purification of target proteins from crude cell extracts. A P-galactosidase (P-
gal) fusion protein containing the C-terminal 119 aminoacids from GA-I (BSB119) 
was used as a model system to study starch binding and elution. Because of 
proteolysis, approximately 40 % of initial P-gal activity lacked the SBD, and the 
remaining fusion protein contained from to one to four SBDs per molecule of a 
P-gal tetramer. The fusion protein forms containing at least one intact SBD 
adsorbed to starch. The bound fusion protein was eluted by using 10 mM 
solutions of various maltooligosaccharides and cyclodextrins. The best eluants 
were 10 mM maltodextrin with an average degree of polymerization (DP) of 10 
and 10 mM P-cyclodextrin. The elution yields of BSB119 with 
maltooligosaccharides of increasing DP suggested that the starch-binding site of 
the SBD consists of at least five glucosyl binding sites. SDS-PAGE gels and 
Western blots showed that the purity of the fusion protein eluted from starch was 
as good or better than that obtained by conventional affinity chromatography. 
Keywords; granular starch; starch-binding domain; p-galactosidase; fusion protein; 
adsorption; elution 
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INTRODUCTION 
Fusion protein systems are becoming a powerful tool for one-step recovery 
and purification of target proteins from a complex mixture of proteins.^ 
Proteins/peptides of various sizes and functionalities have been genetically 
engineered for fusion to virtually any target protein either as a leader (N-terminal) 
or as a tail (C-terminal) fusion. On a laboratory scale, fusion protein technology is 
an elegant approach to a one-step purification of recombinant proteins, but on an 
industrial scale, the cost of the ligand and/or the ligand-carrier could by 
prohibitively high. 
We are interested in utilizing raw starch as a specific adsorbent for 
recovery and purification of fusion proteins that contain the starch-binding 
domain (SBD) of Aspergillus glucoamylase-I (GA-I) as an affinity tail. Our 
previous studies indicated that GA-I adsorbed specifically and strongly to raw 
com starch primarily via its SBD, which is located at the C-terminus of the 
enzyme molecule.^ Chen et al?'^ constructed several fusion proteins by fusing 
fragments of different length from the C-terminal region of GA-I to the 
C-terminus of P-gal. The fusion proteins containing 103,119, and 133 aminoacid 
residues from the C-terminus of GA-I showed significantly higher affinity for 
starch than a p-gal control. The 119 residue fusion protein (BSB119) exhibited the 
highest proteolytic stability and starch affinity. Because rather low elution yields 
(17 %f and a certain degree of nonspecific adsorption to starch of a different 
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p-gal/SBD fusion protein^ were previously observed, we further investigated the 
raw starch binding and elution of BSB119. 
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MATERIALS AND METHODS 
Materials 
Maltose, maltotriose, maltotetraose, maltopentaose, maltohexaose, 
maltoheptaose, isomaltose, and cellobiose were purchased from Sigma Chemical 
Co. (St. Louis, MO). Acarbose was a gift from Dr. J. K. Shetty of Miles 
Laboratories (Elkhart, IN). 
A protease-deficient ( Ion )  E .  co l i  strain Y1089-1 was derived from strain 
Y1089. Plasmid pMC9 was eliminated by growth in non-selective medium."' 
pMC9 harbored the lacP gene and its elimination made the strain constitutive for 
expression of the fused genes under control of a lac promoter. Y1089-1 containing 
the plasmid pLC4 (derived from pUR290), encoding a P-gal fusion protein with 
C-terminal 119 aminoacids of GA-I was obtained from Dr C. Ford of Iowa State 
University."* Fractionated potato starch (particle size 30-50 pm) was provided by 
Dr. J. Jane of Iowa State University, a- and p-cyclodextrins were purchased from 
Sigma, and y-cyclodextrin was a gift from Dr. S. Hizukuri of Kagoshima 
University, Japan. Maltodextrin M-lOO (average DP of 10) was a gift from Grain 
Processing Corporation (Muscatine, lA). p-Gal antibodies were from 
Boehringer-Mannheim Biochemicals (Indianapolis, IN), and GA-I antibodies were 
made by Hybridoma Services at the Instrumentation Facilities of Iowa State 
University. Molecular weight standards for SDS-PAGE gels and prestained 
standards for Western blots were from Bio-Rad, and so were the Protein A-gold 
22 
and silver enhancement kits. 
Preparation of the Fusion Protein 
Transformed E. coli cells containing the plasmid for the fusion protein were 
grown in shake flasks in 1 L LB medium with 60 pg/mL ampicillin.® Cells were 
harvested after the ODggg of the medium reached 1-1.2 absorbance units (which 
corresponds to the midlog phase) by centrifugation for 10 min at 5000 x g. The 
cell pellets were resuspended in pH 7.0 buffer containing 100 mM NaCl, 10 mM 
sodium phosphate, 10 mM MgCl;, 2 mM NaNg, 10 mM P-mercaptoethanol (P-ME), 
5 mM benzamidine, and 5 mM EDTA. Cell disruption was done by two passes 
through a French Press (SLM Aminco) at 4000 psi. Phenylmethanesulfonyl 
fluoride (PMSF) was added (1 mM final concentration) to the suspension as a 
protease inhibitor. After cell disruption, supematants containing crude soluble 
extracts were obtained by centrifugation for 20 min at 30,000 x g. The crude 
extract was treated to 50 % ammonium sulfate saturation, and the solution stirred 
for 30 min at room temperature. The precipitate was collected by centrifugation 
(20 min, 30,000 x g) and redissolved in 5 mL of the buffer described above but 
without benzamidine and EDTA. The redissolved precipitate was desalted either 
on a Bio-Rad P-6DG column (80 x 2.5 cm) or by extensive dialysis against the 
same buffer. 
The desalted crude preparation was used as is for the binding experiments. 
The fusion enzyme was also purified by affinity chromatography on a 
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p-aminophenyl p-D-thiogalactopyranoside-agarose (Sigma) following the method 
of Steers et al7 
Adsorption and Elution of Crude BS6119 from Starch 
A Bio-Rad econo column (10 x 1 cm) with a flow adapter was packed with 
fractionated potato starch of average granular size of at least 50 pm to avoid 
clogging of piston frits and compression of the column. A constant ascending 
flow rate of 0.25 mL/min was maintained by a peristaltic pump. An ISCO 
(Lincoln, NE) UA-5 detector/plotter was used to monitor protein concentration at 
280 run. One mL fractions were collected by an ISCO Retriever n fraction 
collector. The starch column volume was approximately 2.5 mL. The nonspecific 
binding of P-gal to starch observed by Chen et al} was minimized by saturating 
the high-energy sites on the starch granule surface by using 4 mL of 1.5 mg/mL 
bovine serum albumin (BSA). The starch column was washed overnight to 
remove all but strongly adsorbed BSA. 
Pulses of the desalted crude preparation (1-1.5 ml, ca. 20,000 P-gal units) 
were injected on the starch column. After the unbound portion came out of the 
column, the column was washed with 30 mL (12 column volumes) buffer, and the 
bound protein was eluted with various ligands. The same phosphate buffer, as 
described previously, was used. All fractions were collected and analyzed for 
p-gal activity. SDS-PAGE gels and Western blots with P-gal or GA-I antibodies 
were run to identify the peak fractions. 
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Readsorption of BS6119 
A set of experiments was carried out to determine whether the different 
elution ligands can be easily separated from the fusion protein. The fusion 
protein was adsorbed on the starch column and eluted with 500 mM maltose, 
10 mM maltodextrin, or 10 mM p-cyclodextrin. The eluted protein was pooled 
and extensively dialyzed against phosphate buffer (pH 7) by using a Spectrum 
12,000-14,000 MWCO membrane. The dialyzed fusion protein was readsorbed to 
the starch column as described previously and subsequently desorbed by using 
the same eluant as in the first step. 
Specificity of the SBD 
To examine the specificity of the SBD, the desalted ammonium sulfate 
preparation of BSB119 was preincubated with 50 mM maltose, isomaltose, or 
cellobiose. The starch column was also equilibrated with 50 mM of the respective 
disaccharide. The preincubated BSB119 preparation was applied on the column. 
After the unbound fraction of the fusion protein emerged from the column, the 
starch was washed with 12 column volumes of buffer containing 50 mM of the 
respective sugar. The fusion protein that remained adsorbed was eluted with a 
10 mM maltodextrin solution. 
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Analytical Techniques 
Vertical 7.5 % SDS-PAGE gels were run on a Bio-Rad Mini-Protean H gel 
apparatus by using the Laemmli buffer system.® The gels were silver-stained by 
the method of Wray et al? For Western blotting, SDS-PAGE gels were run as 
described, without staining, and the proteins transferred to a 0.2 pm pore size 
nitrocellulose membrane using a Trans-Blot semi-dry electrophoretic transfer 
system from Bio-Rad. The buffer system used was that of Bjerrum and 
Schafer-Nielsen,^° and the transfer was done for 30 min at 10 V. After blocking 
the nitrocellulose membrane with 10 % milk-diluent, it was incubated overnight 
with the appropriate antibodies. The membrane was washed three times for 
5 min with Tris-buffered saline (TBS, Bio-Rad), and the proteins were detected by 
using gold-labeled Protein A. The bands were enhanced by a silver enhancement 
kit from Bio-Rad. 
p-Gal activity was measured by a modification of the method of Miller". 
Samples of enzyme solution (5-20 pL) were brought to 1 mL by the addition of 
Z- buffer (60 mM Na^HPO^, 40 mM NaH^PO^, 10 mM KCl, 1 mM MgSO^, 50 mM 
P-ME, pH 7.0) in a microcuvette. The hydrolysis reaction was started with the 
addition of 0.2 mL of 4 mg/mL o-nitrophenyl p-D-galactopyranoside (ONPG). 
The solutions were mixed gently by inverting the cuvette several times, and then 
the rate of change of absorbance at 420 nm (AA^go/min, 1 cm light path) was 
measured with a Beckman DU-50 spectrophotometer by using Beckman's Kinetics 
Soft-Pac module. The spectrophotometer cell was maintained at 28 °C. One unit 
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of P-gal activity is defined as the amount of enzyme that hydrolyzes 1 nmol of 
ONPG per minute under the assay conditions. Protein concentration was 
measured by Bio-Rad standard/microassay. 
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RESULTS AND DISCUSSION 
Purification and Characterization of the Crude BSB119 
Preliminary characterization of the crude BSB119 consisted of analyzing the 
eluted fractions after injecting a pulse of the crude fusion preparation on the 
potato starch column. The typical elution profile from the starch column is given 
in Figure 1. The first peak in Figure 1 contained about 40 % of the total (3-gal 
activity injected on the column. The second peak represents the (J-gal activity that 
adsorbed to starch and eluted from the column with 10 mM p-cyclodextrrn. 
The identity of the P-gal activities that appeared in the two peaks was 
determined by SDS-PAGE (Figure 2) and Western blot (Figure 3) analysis. The 
two bands on the SDS-PAGE gel (Lane 2) with molecular weights of about 130 
kDa and 116 kDa corresponded to the expected weights of the fusion enzyme and 
degradation product monomers, respectively. The monomer of the degradation 
product has a molecular weight slightly greater than that of commercial P-gal. 
This observation suggests that the proteolytic attack occurs within the SBD near 
the fusion junction. Williamson et al}^ showed that there are at least two sites 
within the 119 aminoacid fragment which are susceptible to serine proteases. The 
Western blot (Lane 2 in Figure 3a and 3b) confirmed that the upper band is that 
of the BSB119 fusion protein because it cross-reacted with both GA-I and P-gal 
antibodies. The composition of the unbound P-gal activity (first peak in Figure 1) 
is shown in Figures 2 and 3 (Lane 3). The upper band of BSB119 detected in 
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Figure 1. Typical elution profile of a crude BSB119 preparation from the starch 
column 
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Figure 2. SDS-PAGE of the various fractions from the starch column. Lanes 1 
and 7, MW standards; Lane 2, desalted crude extract; Lane 3, 
unbound protein fraction; Lane 4, protein fraction eluted with 
10 mM p-cyclodextrin; Lane 5, commercial p-gal; Lane 6, BSB119 
purified on a p-aminophenyl P-D-thiogalactopyranoside-agarose 
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Figure 3. Western blots of the various fractions from the starch column 
hybridized with (A) p-gal antibodies and (B) GA-I antibodies. Lanes 
1 and 8, prestained MW standards; Lane 2, desalted crude extract; 
Lanes 3 and 4, unbound protein fraction; Lane 5, protein fraction 
eluted with 10 mM P-cyclodextrin; Lane 6, BSB119 purified on a 
p-aminophenyl (3-D-thiogalactopyranoside-agarose; Lane 7, (A) 
commercial P-gal and (B) purified GA-I 
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Lane 2 is missing in Lane 3, and only the lower band of P-gal appeared on the gel 
in Lane 3. Because the E. coli strain used in this work does not produce native 
p-gal, it can be concluded that the P-gal band in Lane 3 corresponds to a 
degradation product obtained by cleavage of the SBD from BSB119. In summary, 
the first peak in the elution profile contains P-gal activity, which lacks the SBD 
and hence carmot bind to starch. The second peak represents the fusion protein, 
which bound to starch and subsequently specifically eluted with p-cyclodextrin. 
The analysis of the eluted fusion enzyme with p-cyclodextrin (Lane 4 in Figure 2 
and Lane 5 in Figure 3) shows again the same two bands as in Lane 2. The 
appearance of these two bands suggests that the adsorbed fusion protein is a 
mixture of fusion proteins having one, two, three, and four SBDs per molecule of 
a P-gal tetramer.^ The mixture of BSB119 forms results from the partial 
proteolytic degradation of the full-size fusion protein. The lack of a 130-kDa band 
in the unbound fraction (Lane 3 in Figures 2 and 3) indicated that the fusion 
protein which contains at least one SBD bound to the starch. An illustration of 
the purification of BSB119 on the starch column and corresponding SDS-PAGE 
analysis of the unbound and adsorbed fractions activities is given in Figure 4. 
Multiple fusion forms produced by partial proteolysis of other P-gal fusion 
proteins have been observed before.^^^^ 
We also confirmed that the SBD-starch interactions were responsible for the 
adsorption of the fusion protein on the starch column by comparing the binding 
and elution of the BSB119 to that of native P-gal. The P-gal control, lacking the 
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Figure 4. A schematic illustration of the purification of BSB119 forms on the 
starch column and corresponding SDS-PAGE analysis. A P-gal 
monomer is represented with an open circle, whereas the SBD is 
shown as a smaller filled circle 
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SBD, was produced and loaded on the starch column by following the same 
procedure as for the fusion protein. More than 95 % of the P-gal activity came 
out in the unbound fraction, and none was eluted with 10 mM |3-cyclodextrin. 
Lane 6 in Figure 2 shows the purity of the fusion protein purified on a 
p-aminophenyl p-D-thiogalactopyranoside-agarose column by utilizing P-gal 
affinity for this adsorbent. The purity of this fusion protein is comparable to that 
obtained on the starch column (Lane 4 in Figure 2). The purified fusion proteins 
had specific activities ranging from 128,000 to 140,000 units/nmol which 
compared well to the specific activity of the P-gal control (ca. 140,000 units/nmol). 
Typically, the unbound fraction (Figure 1) accounted for about 40 % of the 
initial p-gal activity, which suggests that approximately 40 % of the original fusion 
protein does not contain a single SBD. In one case, the BSB119 preparation 
contained only 18 % of the activity that did not bind to starch. The exact reason 
for the degradation of the SBD in BSB119 is not known. Chen et al* suggested 
that improper folding of the SBD in E. coli makes this fragment more susceptible 
to proteolysis. Therefore, it can hypothesized that SBDs in the initially full-sized 
BSB119 monomers that folded correctly were stable and functional, and those that 
did not fold properly were degraded. Our results seem to support this hypothesis 
because all fusion proteins with at least one intact starch-binding domain 
adsorbed to starch, and no intact BSB119 protein was found in the unbound 
fraction. We confirmed that the protein degradation occurred predominantly 
in vivo during the production of the fusion protein and not after cell disruption 
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(data not shown). 
Another possible reason for the SBD instability is the lack of glycosylation 
of the SBD in E. coli. The N-terminal 12 aminoacids of the SBD are normally 
glycosylated in GA-I of Aspergillus niger. When the SBD is fused to P-gal and 
produced in E. coli, the normally glycosylated aminoacid residues are no longer 
so, lending them susceptible to cleavage by proteases.^® The stability of fusion 
proteins produced in £. coli is difficult to predict^'' and, in general, truncated 
domains and linker regions are especially susceptible to proteolysis.^® 
Elution of BSB119 from Starch 
The elution of the BSB119 adsorbed on potato starch was investigated by 
using buffered solutions of various sugars (Table 1). The choice of sugars resulted 
from our previous finding that maltooligosaccharides and acarbose eluted GA-I 
from com starch^ and from the data of others who showed that a-cyclodextrin^® 
and P-cyclodextrin"'^° interacted specifically with the SBD of GA-I. A 10 mM 
ligand concentration was selected because of the limited water solubility of 
P-cyclodextrin under the experimental conditions. The values in Table 1 are 
averages of two runs. Approximately 20,000 units of P-gal activity was injected 
on the column in each case. Among the maltooligosaccharides, the yield of the 
desorbed protein increased with their degree of polymerization, up to 
maltohexaose. Using maltoheptaose and maltodextrin of DP=10 as eluting ligands 
did not substantially increase the yield (Figure 5). Assuming specific and 
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Table 1. Elution of BSB119 from starch with different oligosaccharides at 
pH 7.0 and 4 °C 
Eluant Bound BSB119 Yield 
(10 mM) (% of initial) (% of bound) 
Maltose 64 19 
Maltotriose 66 22 
Maltotetraose 66 38 
Maltopentaose 62 60 
Maltohexaose 60 74 
Maltoheptaose 59 75 
Maltodextrin (DP=10) 60 77 
Acarbose 60 52 
a-cyclodextrin 61 75 
P-cyclodextrin 61 76 
y-cyclodextrin 82' 74 
* A different preparation. 
independent binding of the glucosyl residues of maltooligosaccharides to the 
SBD^S we inferred that the SBD possesses at least five subsites, each capable of 
binding one glucosyl residue. This conclusion regarding the size of the starch-
binding site of the SBD is consistent with the data of Belshaw and Williamson^®, 
who estimated that two P-cyclodextrin molecules can bind to the SBD of GA-I. 
Acarbose (a pseudo-tetrasaccharide) eluted 52 % of the bound fusion 
protein compared with 38 % eluted by maltotetraose. The greater yield obtained 
with acarbose than with maltotetraose implies a stronger interaction of acarbose 
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Figure 5. Desorption yield (%) of BSB119 as a function of the degree of 
polymerization of the eluting ligand 
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with the SBD than maltotetraose. The three cyclodextrins (a-, (3-, and 
y-cyclodextrin) were about equally efficient in eluting the BSB119 as 
maltooligosaccharides with a DP > 6. 
Table 2 compares the volumes in which the BSB119 peak was eluted by the 
six best ligands. The yields in Table 2 were estimated from the total P-gal activity 
of the second peak in Figure 1. Maltodextrin (DP=10) and P-cyclodextrin were the 
most effective ligands in desorbing BSB119, followed by maltoheptaose and 
a-cyclodextrin. This qualitative estimate of the affinity of different eluants for the 
SBD agrees well with the data of Savel'ev et al}^ and the most recent results 
obtained in our laboratory." Savel'ev et al}^ determined by equilibrium gel 
filtration that P-cyclodextrin had six times higher affinity for the SBD of GA-I than 
a-cyclodextrin, and Kusnadi" found that P-cyclodextrin interacted with the SBD 
by an order of magnitude stronger than maltoheptaose. 
Table 2. Comparison of the six best eluants for the elution of BSB119 from 
starch at pH 7.0 and 4 °C 
Eluant Yield Elution Volume 
(10 mM) (%) (mL) 
Maltohexaose 74 9.9 
Maltoheptaose 75 8.5 
Maltodextrin (DP=10) 77 7.5 
a-cyclodextrin 75 9.0 
p-cyclodextrin 76 7.6 
y-cyclodextrin 74 10.3 
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Readsorption of BSB119 
The choice of the eluting ligand, besides cost, will also depend on the end 
use of the fusion protein. If the SBD has to be cleaved from the fusion protein, 
the mixture of the native protein and SBD can be separated by readsorbing the 
SBD to starch. The ultimate choice of the eluant in such instances will depend on 
the ease of dissociation and separation of the ligand from SBD. We found that 
P'cyclodextrin and maltodextrin (DP=10), having higher affinity for the SBD, were 
more difficult to dialyze out than maltose. Therefore, whenever readsorption of 
the BSB119 or SBD is required, we recommend the use a 500 mM maltose 
solution, which is as effective as 10 mM p-cyclodextrin in desorbing the fusion 
protein from the starch column.^ 
Specificity of the SBD 
To confirm the affinity of the SBD for a-1,4 glucosyl oligosaccharides we 
investigated the inhibition effect of maltose, isomaltose, and cellobiose on BSB119 
adsorption to starch. The results in Table 3 show that only maltose was able to 
inhibit the adsorption of the fusion protein to any significant extent. The amount 
of the fusion protein in the unbound fraction increased from 18 to 33 % due to 
maltose competitively binding at the starch-binding site. The other two unbound 
fractions detected in the presence of isomaltose and cellobiose were similar 
(within experimental error) to that of the uninhibited enzyme fusion. We also 
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verified the activity and functionality of the adsorbed BSB119 fraction by eluting it 
with 10 mM maltodextrin (Table 3). 
Table 3. Inhibition of BSB119 adsorption to starch 
Inhibitor Unbound Eluted' 
(% of initial) (% of bound) 
none 18 73 
50 mM maltose 33 68 
50 mM isomaltose 20 90 
50 mM cellobiose 19 73 
' Eluted with 10 mM maltodextrin. 
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CONCLUSIONS 
We have shown that a crude preparation of a p-gal fusion protein 
containing a 119 aminoacid segment from the C-terminus of GA-I from A. niger 
can be purified by a single adsorption step using starch. The bound fusion 
protein can be effectively eluted from raw starch by using a variety of a-1,4 
glucosyl oligosaccharides, which proves the specific nature of interactions between 
the SBD and starch. Mild elution conditions, wide selection of eluting ligands, 
and low cost of the starch adsorbent are important prerequisites that make this 
system attractive for further process development. If the removal of SBD is 
required, a specific enzymatic (thrombin. Factor Xa, collagenase etc.) cleavage site^ 
can be inserted between the target protein and the SBD. We have successfully 
used a Factor Xa cleavage site to remove and purify the SBD from a maltose 
binding protein-SBD fusion.^^ 
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INTRODUCTION 
We are developing an economical recovery and purification system for 
genetically engineered proteins that contain the starch-binding domain (SBD) of 
Aspergillus glucoamylase-I (GA-I). The basis for separation of the engineered 
proteins is the specific interaction of the SBD with raw starch allowing the use of 
starch as an affinity adsorbent. 
We have previously fused various sizes of the SBD to P-galactosidase 
(P-gal) and showed that the fusion proteins produced bind to starch and retain 
their P-gal activity.^'^ In vivo degradation of the SBD produced heterologous 
fusion proteins containing from one to four SBDs per molecule of a P-gal 
tetramer.^"^ 
To demonstrate the versatility of the SBD fusion system, a glutathione 
S-transferase (GST) fusion protein containing the SBD at the C-terminus was 
constructed. GST was chosen because it is a monomer rather than a tetramer and 
a smaller protein than P-gal (26 kDa vs 116 kDa). In addition, GST has a 
convenient activity assay^ and can be easily purified by affinity chromatography 
on immobilized glutathione.® A number of stable fusions to GST have been made^ 
and the majority of them (36 out of 47) were soluble when produced in E. coli at 
high expression levels. 
This article describes the production and preliminary characterization of the 
GST-SBD fusion protein. 
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MATERIALS AND METHODS 
Flasmids and Strains 
Plasmid pGEX-2T was purchased from Pharmacia. Plasmid pREl 
containing the GA-I gene was obtained from Dr. Ford of Iowa State University. 
The E. coli strain TGI [supEhsdA5thiMlac-proAB)F'(traD36proAB*lacFlacZAM15)] 
was also obtained from Dr. Ford. E. coli strain TBI [FaraA(lac-proAB)rpsL(St/) 
(^80dA(lacZ)M15)hsdR(r,^'m,^*)] was a gift from New England Biolabs (Beverly, MA). 
Construction of the Fusion 
The GST Gene Fusion System was purchased from Pharmacia LKB 
Biotechnology Inc. (Piscataway, NJ). The vector features the GST gene from 
Schistosoma japonicum, a parasitic helminth, and a multiple cloning site (MCS) 
downstream for the insertion of the gene encoding the SBD. A choice of two site-
specific protease sites, thrombin or factor X,, is available to cleave the GST from 
the SBD. The protease recognition sequences are located between the GST gene 
and the MCS. 
A gene fusion encoding a GST fusion protein to the SBD (119 aminoacids 
(498-616) from the C-terminus of GA-I) was constructed by cloning a NheJ - EcoRI 
fragment from pREl into the MCS of vector pGEX-2T at the 3' end of the GST 
gene. Standard molecular cloning techniques^ were used. 
To prepare the insert, pREl was cut with Nhel and EcoRI and the 5' 
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overhangs generated were partially filled in by incubating at room temperature 
for 10 min with Klenow and a nucleotide mixture without dGTP. The reaction 
was stopped by adding EDTA to a final concentration of 25 mM. The 0.5 kb 
fragment was purified by agarose gel electrophoresis followed by Gene-Clean (Bio 
101 Inc., La Jolla, CA). The vector was prepared as follows; pGEX-2T was cut 
with BamHJ and EcoRI and the 5' overhangs were partially filled in as before but 
this time without dCTP. The cut vector was purified as before. Ligations were 
setup at a vector to insert ratio of 1:5 and 1:10 and carried out for 24 hours at 
14 °C. Competent TGI cells were prepared and transformed with the ligation 
products and plated on LB+Ampicillin (Amp, 75 pg/mL) plates. Transformed 
colonies were picked and plasmid DNA purified by a mini-prep procedure.^ 
Single insertion and correct orientation of the insert was confirmed by restriction 
mapping. Sequencing to verify an in-frame fusion was done by using a primer 
(5'-GCATGGCC l i lGCAGGG-3') homologous to the DNA sequence near the 3' 
end of the GST gene. Primer synthesis and sequencing were done at the Iowa 
State University Nucleic Acid Facility. 
Finally, a single transformant was picked and maintained on LB+Amp 
plates. The fusion protein with GST at the N-terminus and a 119 aminoacid-long 
SBD at the C-terminus was named GSB119. The plasmid encoding GSB119 
(pBIPS) was purified from TGI and used to transform competent £. coli strain 
TBI. Both TGI and TBI were also transformed with pGEX-2T, the unmodified 
vector, to produce wild-type GST (WT-GST) that would serve as a control to 
check the expression, production, and the specific activity of the fusion protein. 
Small-Scale Production of GST and GSB119 
Transformed E. coli cells with the plasmid for GSB119 (pBIP3) or WT-GST 
(pGEX-2T) were grown in LB media containing 60 pg/mL ampicillin. Two 
milliliters of an overnight culture were inoculated into 100 mL of fresh LB+Amp 
media in a shake flask. The flask was shaken for 3-4 hours at 37 °C and 200 rpm 
until the ODggg value reached approximately 1.0. The culture was then induced to 
produce the desired protein by adding IPTG. Four different EPTG concentrations 
(0.1, 0.2, 0.5, and 1.0 mM) were studied. After IPTG addition, the flask was 
further shaken at 25 °C or 37 °C for 1 or 2 hours. Cells were harvested by 
centrifugation for 10 min at 5000 x g. The cell pellet was suspended in 5 mL of 
lysis buffer (150 mM NaCl, 16 mM NazHPO^, 4 mM NaHgPO^, 1 % Triton X-100, 
5 mM benzamidine, 2 mM EDTA, 0.1 % P-mercaptoethanol, pH 6.5) and passed 
twice through a French Press (SLM Aminco) at 4000 psi. Phenylmethanesulfonyl 
fluoride (PMSF) was added (1 mM final concentration) to the lysed suspension as 
a protease inhibitor. Cell debris was separated by high-speed centrifugation 
(20 min at 30000 x g) and the supernatant collected. The cell-debris pellet was 
rinsed and resuspended in 5 mL of water to analyze for inclusion bodies. 
Inclusion body formation was also confirmed visually by examining intact cells 
before and after induction under a phase-contrast microscope. 
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Purification of GST and GSB119 
WT-GST and GSB119 were purified from the respective cell-free extracts by 
affinity chromatography on a glutathione-agarose column.® Unbound and non-
specifically bound proteins were removed by extensive washing with MTPBS 
buffer.® Bound protein was eluted by competition with 5 mM free reduced 
glutathione in a 50 mM Tris-HCl buffer (pH 8.0). Eluted protein was dialyzed in 
a Spectrapor 3 membrane (MWCO; 3500) against MTPBS to exchange the buffer 
and remove glutathione. The initial, unbound, and eluted fractions were analyzed 
for GST activity and also on SDS-PAGE gels and Western blots. 
Starch Binding and Elution 
A Bio-Rad econo column (20 x 1 cm) with a flow adapter was packed with 
fractionated potato starch of average granular size of 50 pm. A constant 
ascending flow rate of 0.35 mL/min was maintained by a peristaltic pump. One 
milliliter pulses of purified WT-GST and GSB119 were injected on the starch 
column. After the unbound portion came out of the column, the column was 
washed with 25 mL (10 column volumes) of buffer, and the bound protein eluted 
with 10 mM P-cyclodextrin. All fractions were collected and analyzed for GST 
activity. SDS-PAGE gels and Western blots with GA-I antibodies were run to 
identify the peak fractions. 
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Analytical Techniques 
Vertical 12 % SDS-PAGE gels were run on a Bio-Rad Mini-Protean II gel 
apparatus by using the Laemmli buffer system.® Whole cell samples were 
prepared by taking 0.1 mL of culture in an Eppendorf tube, centrifuging, 
removing supernatant and boiling the cell pellet in 0.1 mL SDS sample-treatment 
buffer. An equivalent of 5 pL of culture was loaded per lane of the gels. The gels 
were silver-stained by the method of Wray et al.^ GST activity was measured 
according to Habig et al.'^ The substrate solution was prepared by adding 1 mL 
each of 25 mM freshly prepared reduced glutathione in water and 25 mM 
l-chloro-2,4-dirûtrobenzene (CDNB) in ethanol to 23 mL of a 100 mM potassium 
phosphate buffer (pH 6.5). The rate of change of absorbance at 340 nm 
(AA34o/min, 1 cm light path) at room temperature was measured with a Beckman 
DU-50 spectrophotometer by using Beckman's Kinetics Soft-Pac module. One unit 
of GST activity is defined as the amount of enzyme that conjugates glutathione 
and CDNB to form 1 nmol of product per minute under the assay conditions. 
Protein concentration was measured by Bio-Rad standard/microassay. 
RESULTS AND DISCUSSION 
Purification of WT-GST and GSB119 
Figure 1 shows the purification of the two proteins on the glutathione-
agarose column. WT-GST is the native glutathione S-transferase produced from 
the unmodified plasmid, while GSB119 is the fusion protein of GST with the SBD 
of GA-I. Lanes 2-4 correspond to WT-GST and lanes 5-7 to GSB119. Lane 2 
shows a strong band at about 26 kDa which corresponds to the expected 
molecular weight of WT-GST. The 26-kDa band almost disappears from lane 3, 
indicating adsorption of WT-GST to glutathione-agarose. Lane 4 shows a single 
band at 26 kDa corresponding to purified WT-GST. The major band in the 
purified fraction for GSB119 (lane 7) has the expected molecular weight of 40 kDa. 
The appearance of protein bands in lane 7 corresponding to molecular weights 
between 26 kDa (the molecular weight of WT-GST) and 40 kDa suggest 
proteolytic degradation of the fusion protein within the SBD domain. Similar 
degradation also occurred with P-galactosidase-SBD fusion proteins.^-^ Western 
blotting with polyclonal GA-I antibodies confirmed the identity of the fusion 
protein by hybridizing to the 40 kDa band (data not shown). However, the GA-I 
antibodies did not recognize any of the degradation products and GST antibodies 
were unavailable. 
The amount of soluble GSB119 in the crude extract was very small 
compared to WT-GST (lane 2 vs 5). The total amount of GSB119 eluted from the 
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1 2 3 4 5 6 7 8 
—97 kDa 
-^66 kDa 
"*-45 kDa 
-*-31 kDa 
"*-21 kDa 
^14 kDa 
Figure 1. Purification of WT-GST and GSB119 on glutathione-agarose. Lanes 1 
and 8: MW markers; Lane 2: Crude extract, WT-GST; Lane 3: 
Unbound, WT-GST; Lane 4: Eluted, WT-GST; Lane 5: Crude extract, 
GSB119; Lane 6: Unbound, GSB119; Lane 7: Eluted, GSB119 
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glutathione-agarose column was only 3 mg compared to 71 mg of WT-GST, 
GSB119 activity in the soluble cell-free extract was 980 U/mL compared to 9147 
U/mL for WT-GST. The low level of GSB119 in the soluble extract led us to 
suspect in vivo protein aggregation or inclusion body formation when GSB119 is 
produced in TGI. Approximately 15 % of total cellular protein was GST, 
indicating very good expression. The specific activity of purified GSB119 on a 
molar basis was about the same as that of WT-GST, indicating no loss of GST 
activity upon fusion to SBD. 
Inclusion Body Formation with GSB119 
Inclusion body formation was confirmed by analyzing the cell-debris pellet 
after cell disruption and centrifugation by SDS-PAGE. The presence of a major 
band at 40 kDa in the cell debris would indicate that the fusion protein was 
produced in sufficient quantities, but it was not soluble. Figure 2 shows the 
results from one such experiment. Lane 2 contains a whole cell sample before 
induction and, as expected, does not show a GSB119 band at 40 kDa. Lane 3 has 
a whole cell sample after induction and shows a major band at 40 kDa, indicating 
good expression and production of the fusion protein. Lanes 4 and 5 are the cell-
debris pellet (resuspended in water) and the soluble cell-free extract, respectively. 
The data from lanes 4 and 5 suggest that most of the fusion protein is present in 
the cell-debris fraction and very little in the soluble extract. Inclusion bodies were 
confirmed by visually observing intact cells after induction under a phase-contrast 
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1 2 3 4 5 6 
—97 kDa 
"*-66 kDa 
"*-45 kDa 
r31 kDa 
^WT-GST 
•^21 kDa 
-^14 kDa 
Figure 2. Production of GSB119 in TGI. Lanes 1 and 6: MW markers; Lane 2: 
Before induction; Lane 3: After induction; Lane 4: Cell-debris 
fraction; Lane 5: crude soluble extract 
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microscope. They appeared as refractile spherical aggregates at the poles of the 
oblong E. coli cells.^" Lane 4 does not show a ladder of bands between 40 kDa 
and 26 kDa as with purified GSB119 (Fig, 1, lane 7). This indicates that the 
aggregated fusion protein present in vivo as inclusion bodies is protected from 
proteolysis. 
Inclusion bodies were also formed with P-gal-SBD fusion proteins but 
approximately 50 % of the fusion protein was soluble. A third fusion protein, 
produced by fusing the maltose-binding protein of E. coli with the SBD", did not 
form inclusion bodies but remained soluble and functional even when produced 
at very high levels in E. coli (data not shown). Hence, it seems that the SBD is not 
responsible for inclusion body formation. The lack of understanding of all factors 
affecting inclusion body formation prevents any a priori prediction of the fate of 
SBD fusions. 
Inclusion body formation for fusion proteins with GST has been observed 
before by Smith and Johnson® but only in 11 out of 47 cases. However, Hartman 
et al}^ made five different fusions with GST and found them all packaged in 
insoluble form in E. coli. Schein" found that reducing the growth temperature 
after induction can reduce or even eliminate inclusion body formation in some 
cases. The latter was not successful with our fusion protein. We have varied a 
number of factors that could possibly influence inclusion body formation. These 
included the bacterial strain (TGI and TBI), the growth medium. (LB, 2YT, and 
minimal), the cell-density (or growth phase) at induction, the level of EPTG 
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induction (0.1, 0.2, 0.5, and 1.0 mM), the temperature of growth after induction 
(37 °C and 25 °C), the length of growth time after induction ( 1 to 2 hours), and 
the presence or absence of p-mercaptoethanol in the lysis buffer (which may 
influence disulfide bond formation and lead to aggregation). None of these 
conditions could completely eliminate or even sufficiently reduce inclusion body 
formation with the GSB119 fusion protein. 
Starch Binding and Elution 
Purified GSB119 from the glutathione-agarose column was used to study 
binding and elution from starch. Figure 3 shows that the fusion protein can bind 
starch, indicating that the SBD is functional when attached to GST. Lane 2 
contains GSB119 purified from the glutathione-agarose column that was injected 
in the starch column. Lane 3 is the unbound fraction from the starch column and 
shows that some intact fusion protein did not bind to the column. Because a 
small pulse (approx. 0.8 mg) was injected the capacity of the starch column could 
not have been exceeded. This implies that the SBD in a portion of the intact 
fusion may not be folded correctly. The bound protein was eluted with 10 mM 
p-cyclodextrin and appears as a single band of full-length GSB119. The latter 
result suggests that none of the degraded fusion protein can bind to starch and 
that the complete SBD, correctly folded, is required for binding. Lanes 5 to 7 are 
the same as lanes 2 to 4, overloaded to see any minor bands. 
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1 2 3 4 5 6 7 8 
—97 kDa 
—66 kDa 
^45 kDa 
r31 kDa 
^WT-GST 
"*-21 kDa 
"*-14 kDa 
Figure 3. Binding and elation of GSB119 from starch. Lanes 1 and 8: MW 
markers; Lanes 2 and 5: GSB119 purified on glutathione-agarose; 
Lanes 3 and 6: GSB119 unbound to starch; Lanes 4 and 7: GSB119 
eluted from starch 
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CONCLUSIONS 
A fusion protein was constructed containing glutathione S-transferase at the 
N-terminus and SBD at the C-terminus with a thrombin cleavage site between 
them. When expressed in E. coli, the fusion protein formed inclusion bodies, 
irrespective of the culture conditions employed. Inclusion bodies are insoluble in 
ordinary aqueous buffers and require the use of strong dénaturants for 
solubilization.^^ In order to utilize starch as an affinity adsorbent for purification 
of fusion proteins, they should remain soluble and functional. Reagents used to 
solubilize inclusion bodies would also solubilize starch and hence prevent its use 
as an adsorbent. 
Various methods to reduce and/or eliminate inclusion body formation, 
which have been successful in many cases, did not work with GSB119. 
GSB119 was purified on starch from the cell-free extract, but this particular 
fusion protein is not suitable to carry out investigation on a large scale because a 
very small fraction of it was soluble. This work, in conjunction with our previous 
SBD fusion studies/ " shows that the SBD can be attached to different proteins 
without affecting their function and allowing their purification on starch. 
However, a commercially viable process which utilizes raw starch for recovery 
and purification would only be possible for SBD fusion proteins produced in a 
soluble form. 
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ABSTRACT 
This study addresses the interactions of two different starch-binding 
domains with starch and a possible application of either domain as an 'affinity 
tag' for recovery and purification of fusion proteins. The starch-binding domains 
of glucoamylase-I (SBD of GA-I) from Aspergillus niger and of cyclodextrin 
glucanotransferase (domain E of CGTase) from Bacillus macerans were fused to the 
C-terminus of P-galactosidase (P-gal). When produced in £. coli, the majority of 
these fusion proteins formed inclusion bodies with only a small fraction being 
soluble. The soluble fusion proteins were concentrated by ammonium sulfate 
precipitation. After desalting, the crude enzyme preparation was used to study 
the binding and elution characteristics of the two fusion proteins on a starch 
column. Active fusion proteins were purified by partial solubilization of the 
inclusion bodies with 2 M urea followed by affinity chromatography. The 
purified proteins were used to generate adsorption isotherms on starch and cross-
linked amylose with wt-p-gal as the control. 
The starch-binding results show that domain E is an independent domain 
and that it preserves its starch-binding activity when attached to P-gal, similar to 
the SBD. Purification of the fusion proteins by adsorption to insoluble starch and 
elution with various linear and cyclic oligosaccharides was achieved. The results 
of the adsorption isotherms point to some differences in the structure of the two 
domains. 
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INTRODUCTION 
Cyclodextrin glucanotransferases (CGTases, EC 2.4.1.19) are monomeric 
extracellular Bacillus enzymes that catalyze the degradation of starch to 
cyclodextrins and to transglycosylated linear chains by the following two reactions 
(Bender 1986): 
Gn ^ G(n.x) + cGx (cyclization, coupling: n > 8; 9 > x > 6) (1) 
Gn + G^ ^ G(n.x) + G(m+x) (disproportionation: n > 3, m > 1; x > 1) (2) 
where G^ and G^ are a(l->4)-glucopyranosyl chains of length n and m, cG^ are 
cyclodextrins of ring size x. 
CGTases are divided into a, p and y producers, depending upon the major 
type of cyclodextrin formed by them. There is strong sequence and structural 
homology between CGTases and various amylases (MacGregor and Svensson 
1989). The raw starch binding and degrading ability of both amylases and 
CGTases and the sequence homology between their C-terminal regions suggested 
that CGTases possess a raw-starch binding site separate from the active site, 
similar to many amylases and glucoamylases (Svensson et al. 1989). 
The CGTase from Bacillus circulans (strain 8) has been crystallized and its 
three-dimensional structure described at 3.4 Â and 2.0 Â resolution (Hofmann 
et al. 1989, Klein and Schulz 1991). The 3-D structure of Bacillus stearothermophilus 
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CGTase has also been described (Kubota et al. 1990 and 1991) and shows striking 
similarity to the structure of the Bacillus circulans CGTase. However the 
B. stearothermophilus structure was divided into only four domains A, B, C and D, 
while the overall structure of the B. circulans (strain 8) CGTase was divided into 5 
domains, named A, B, C, D and E. This difference in nomenclature is merely due 
to Kubota et al. lumping the first two domains together as one domain. Very 
recently, the 3-D structure of another CGTase from Bacillus circulans (strain 251) 
was reported (Lawson et al. 1994). The two B. circulans CGTases have 75 % 
sequence homology and their structures are essentially the same. 
Many investigators have tried to explain the role of domain E in CGTase. 
Hellman and coworkers created several truncated forms of the CGTase from 
Bacillus circulans var. alkalophilus and compared their starch-degrading and 
cyclization activities to the wild-type enzyme (Hellman et al. 1990). Of the four 
truncated enzymes, the two lacking 36 and 84 aminoacids from the C-terminus 
had both their starch-degrading and cyclization activities reduced to 0.5 % of that 
of the native enzyme. The other two, lacking 125 and 225 aminoacids from the 
C-terminus, had completely lost both the activities. This led to the conclusion that 
domain E is involved in the starch-degrading as well as the cyclization activities 
of the enzyme. When alkaline phosphatase was fused to the C-terminal end of 
the CGTase lacking 36 residues, the CGTase cyclization activity was partly 
recovered, suggesting a possible stabilization effect of domain E rather than a 
more direct role in the catalysis reaction. Deletion of 10 and 13 residues from the 
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C-terminus of a CGTase from Bacillus sp. #1011 led to altered cyclization 
selectivity of the enzyme without changing its starch-degrading activity (Kimura 
et al 1989). 
We have previously reported the results from our work on the starch-
binding domain (SBD) of GA-I from Aspergillus niger (Dalmia and Nikolov 1991 
and 1994). The SBD was found to be an independent domain, fully functional in 
its starch-binding activity when attached to P-gal and produced in £. coli as a 
fusion protein (Chen et al. 1991a and 1991b, Dalmia and Nikolov 1994). The 
sequence similarities between the SBD of GA-I and domain E of CGTase were 
analyzed by Svensson et al. (1989) and they reported 40 % identity and 60 % 
homology between the two starch-binding domains. Besides the sequence 
homology, there are other similarities between the two domains. CGTase has six 
to eight P-strands (Kubota et al. 1991, Klein and Schulz 1991), and the SBD of 
GA-I has a high percentage of residues in P-strands as determined by circular 
dichroism (Williamson et al. 1992). Both domains show tight binding to 
P-cyclodextrin (Villette et al. 1992, Dalmia and Nikolov 1994), as well as to raw 
starch. Villette and coworkers reported a 50-fold higher affinity towards raw 
starch for CGTase (Villette et al. 1992) compared to the value reported by 
Takahashi (Takahashi et al. 1985) for glucoamylase from Rhizopus sp. 
All the work reported so far in characterizing the domain E of CGTase has 
been done with intact enzymes or partially truncated ones and it has never been 
shown directly that the domain E of CGTase, which is presumably the starch-
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binding domain of the enzyme, is independent and functional when separated 
from the other four domains in CGTase. Based on the sequence and structural 
similarities between the two domains, we expected that a P-gal fusion protein 
containing the domain E of CGTase would interact with starch very similarly to 
the P-gal fusion protein with the SBD of GA-I. 
In this article, we describe the construction and preliminary characterization 
of a p-gal fusion protein with the C-terminal 109 aminoacids (containing domain 
E) of CGTase. The raw-starch binding properties of the fusion protein were 
studied and compared to the binding characteristics of our previous P-gal fusion 
protein with the SBD of GA-I (Dalmia and Nikolov 1994). Adsorption isotherms 
for the two fusion proteins on starch and cross-linked amylose were compared 
and gave valuable hints into the structural similarities and differences between the 
two domains. 
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MATERIALS AND METHODS 
Materials 
Plasmids pUR291 and pLCGTl were kind gifts from Dr. Ruther (Ruther 
and Muller-Hill 1983) and Dr. Tao (Lee and Tao 1994) respectively. E. coli strain 
TGI [supEhsdA5thiA(lac-proAB)F'(traD36proAB*lacNacZAM15)] was obtained from 
Dr. Ford of Iowa State University. Raw com and potato starches were purchased 
from Sigma Chemical Co. (St. Louis, MO). Maltohexaose, maltoheptaose, and 
a- and p-cyclodextrin were purchased from Sigma. y-Cyclodextrin was a gift 
from Professor S. Hizukuri of Kagoshima University, Japan. Maltodextrin M-lOO, 
with an average degree of polymerization of 10, was provided by Grain 
Processing Corporation, Muscatine, lA. All other reagents used were of analytical 
grade. 
Construction of the Gene Fusion 
The plasmid pLC4 which codes for the fusion protein BSB119 (Figure 1) 
was obtained from Dr. Ford of Iowa State University. Its construction, starting 
with the pUR290 expression vector, has been described previously (Chen et al. 
1991a). This section describes the construction of pBKDl, which codes for the 
fusion protein BDE109 (Figure 1). The expression vector pUR291 (Ruther and 
Muller-Hill 1983) was used to fuse the N-terminus of the coding sequence for the 
domain E of CGTase to the C-terminus of the lacZ gene for P-gal. Figure 2 shows 
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the cloning steps. Standard molecular cloning techniques were used (Sambrook 
et al. 1989). A 0.5 kb HmdIII fragment from pLCGTl (Lee and Tao 1994) was 
purified and inserted into the HmdIII site in the multiple cloning region of 
pUR291. The vector was cut with HmdIII and dephosphorylated to minimize self-
ligation of the vector and hence reduce non-recombinant background. E. coli 
strain TGI was transformed and plated on ampicillin containing LB plates. 
Several recombinants were picked and checked for single insertion and correct 
orientation of the insert by restriction mapping. One recombinant was selected 
and an in-frame fusion confirmed by sequencing with a 3' lacZ primer 
(5'-GCGGAATTCCAGCTGAG-3'). The sequencing was performed at the Iowa 
BSB119 
1020 1021 1022 1023 498 499 
— Trp Cys Gin Lys Gly Asp Pro Ser Lys — ^  
B-Gal SBD of GA-I 
BDE109 
1020 1021 579 680 
— Trp Cys Arg Gly Ser Val Asp Leu Gin Pro Ser Phe — 
B-Gal Domain E of CGT 
Figure 1. Schematic illustration of the fusion proteins, BSB119 and BDE109, 
showing the aminoacids in the linker region. The numbers 
correspond to the respective residues in the native enzymes 
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Hndlll 
BamH 
pUR291 
5.35 Kb 
Plac 
cut with Hindlll 
dephosphoryiate 5' ends 
Hindlll 
Domain E 
CGT pLCGTl 
6.20 Kb 
indlll 
Indlll 
F1 ori 
cut with Hindlll 
purify 0.5 l<b fragment 
Hindlll Hindlll 
• 
Domain E 
Iigate 
Domain E 
Hindlll 
BamHI pBKDI 
5.85 Kb 
EcoRl 
Figure 2. Construction of pBKDl, Details are described in the text 
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State University Nucleic Acid Facility. This plasmid construct was called pBKDl 
and the clone was used to produce the p-gal-domain E fusion protein, which was 
designated BDE109. 
Preparation of Crude Extracts of BSB119, BDE109 and WT-p-Gal 
Both fusion proteins and wt-P-gal were produced by a slight modification 
of procedures already described by Dalmia and Nikolov (1994). The main 
difference is that the E. coli strain used (TGI) harbored a lacP gene on the 
F' episome, which makes the expression of the genes inducible under control of 
the lac promoter. E. coli cells containing the respective plasmids for the three 
proteins (pLC4 for BSB119, pBKDl for BDE109 and unmodified pUR291 for 
wt-P-gal) were grown overnight in 2YT medium containing 75 pg/mL ampicillin 
(amp). Twenty milliliters of the overnight culture were inoculated into 1 L of 
fresh 2YT+amp (60 yig/mL) media in a shake flask. The flask was shaken for 2-3 
h at 37 °C and 200 rpm until the ODggo value reached approximately 1. The 
culture was cooled to 25 °C and induced with 0.1 mM IPTG to produce the 
desired protein. After IPTG addition, the flask was further shaken at 25 °C for 
2 h. Cells were harvested by centrifugation for 10 minutes at 5000 x g. The cell 
pellets were resuspended in 25 mL of lysis buffer containing 100 mM NaCl, 
10 mM sodium phosphate, pH 7.0,10 mM MgCl;, 2 mM NaNg, 10 mM 
P-mercaptoethanol (p-ME), 5 mM benzamidine, and 5 mM EDTA. Cell disruption 
was done by two passes through a French Press (SLM Aminco) at 4000 psi. 
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Phenylmethanesulfonyl fluoride (PMSF) was added (1 mM final concentration) to 
the suspension as a protease inhibitor. After cell disruption, supematants 
containing crude soluble extracts were obtained by centrifugation for 20 min at 
30,000 X g. The crude extract was treated to 50 % ammonium sulfate saturation, 
and the solution stirred for 30 min at room temperature. The precipitate was 
collected by centrifugation (20 min, 30,000 x g) and redissolved in 10 mL of the 
buffer described above but without benzamidine and EDTA. The redissolved 
precipitate was desalted by extensive dialysis against the same buffer or by 
running the redissolved precipitate on a 2.5 cm x 100 cm desalting column (SR 
column system, Pharmacia, Piscataway, NJ) packed with 400 mL of Bio-Gel P-6DG 
(Bio-Rad, Richmond, CA). The desalted crude preparations for the two fusion 
proteins were used without further treatment for binding and elution experiments 
on a starch column. 
Preparation of Purified BSB119, BDE109 and WT-p-Gal 
WT-p-gal was purified by affinity chromatography (Steers et al. 1971) by 
loading the crude enzyme extract on a p-aminophenyl p-D-thiogalactopyranoside 
agarose column (Sigma) with a flow rate of 1 mL/min in ascending direction. 
After washing the column with at least 10 bed volumes of equilibration buffer 
(50 mM TRIS-HCl, 2 mM NaNg, 500 mM NaCl, 10 mM MgCl^, 10 mM P-ME, 
pH 7) the bound enzyme was eluted with borate buffer (100 mM NazB^Oy, 10 mM 
MgCl;, 10 mM P-ME, pH 10.05). Because of salt precipitation in the borate buffer 
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when cooled to 4 °C, the buffer had to be stored at 4 "C for at least 12 h and 
filtered through Whatman #1 paper just before use to avoid formation of 
precipitate on the affinity column during elution. Small fractions (ca. 4 mL) of 
eluted enzyme were collected directly into tubes containing an equal volume of 
the 500 mM TRIS-HCl buffer, pH 7, to minimize exposure of the eluted enzyme to 
a high pH. Tubes with p-gal activity were pooled and concentrated once again by 
50 % ammonium sulfate precipitation and the resuspended pellet was dialyzed 
against 10 mM sodium phosphate buffer, pH 7.0, containing 100 mM NaCl, 
10 mM MgClg, 2 mM NaNg, and 10 mM P-mercaptoethanol. 
For purification of BSB119 and BDE109, inclusion bodies formed in the 
cytoplasm of the host cells were partially solubilized with 2 M urea. The 2 M 
urea treatment partially solubilized the inclusion bodies and increased the 
recoveries. The cell debris pellet (containing the inclusion bodies) was 
resuspended in 25 mL lysis buffer with 2 M urea and 50 mM P-ME using a 
sonicator equipped with a micro-tip in two intervals of 20 s with intermediate 
cooling in an ice-water bath. The cell debris suspension was shaken at 4 °C for 
1 h, then centrifuged for 45 min at 39,000 x g. The supernatant, containing the 
urea solubilized fraction, was concentrated by 50 % ammonium sulfate 
precipitation, the pellet dissolved in a small amount of buffer and desalted on the 
Bio-Gel P-6DG column. All subsequent steps were the same as in the purification 
of wt-p-gal. The purified proteins were used to generate adsorption isotherms on 
starch and cross-linked amylose. 
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Starch Column Studies 
A Bio-Rad econo column (1 cm x 10 cm) with a flow adapter was packed 
with 2.5 mL of fractionated potato starch. The potato starch was fractionated by 
filtering a suspension in water several times through a 53 |im Spectra/Mesh nylon 
filter from Spectrum (Los Angeles, CA). During the column operation, a constant 
ascending flow rate of 0.235 mL/min was maintained by a peristaltic pump. An 
ISCO (Lincoln, NE) UA-5 detector/plotter was used to monitor protein 
concentration at 280 nm. One mL fractions were collected by an ISCO Retriever 11 
fraction collector. The nonspecific binding of p-gal to starch observed by Chen 
et al. (Chen et al. 1991a) was minimized by saturating the starch granule surface 
by using 8 mL of 1 mg/mL bovine serum albumin (BSA). The starch column was 
washed with 10 mM sodium phosphate buffer (containing 10 mM MgCl;, 100 mM 
NaCl and 10 mM P-ME, pH 7.0) overnight to remove all but strongly adsorbed 
BSA. 
Pulses of the desalted crude preparation (0.47 mL, ca. 27,000 P-gal units) 
were injected on the starch column. After the unbound portion came out of the 
column, the column was washed with 30 mL (12 column volumes) buffer, and the 
bound protein was eluted by adding various ligands in the wash buffer. The 
same phosphate buffer, as described previously, was used. All fractions were 
collected and analyzed for p-gal activity. Collected protein fractions were 
analysed by SDS-PAGE and Western blotting with p-gal antibodies. 
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Adsorption Isotherms 
Adsorption of affinity purified fusion enzymes and wt-P-gal on raw com 
starch (Sigma) and cross-linked amylose (New England Biolabs, Beverly, MA) was 
carried out at 4 °C. Aliquots of 0.1 g raw com starch and 0.01 g cross-linked 
amylose were weighed in 1.5 mL microcentrifuge tubes, respectively. Starch was 
rinsed with 0.5 mL phosphate buffer for 10 min, the suspension centrifuged for 
2 min at 13,600 x g and the supernatant removed. Cross-linked amylose could not 
be washed in the same manner due to difficulties in removing the buffer without 
taking out parts of the resin. Therefore, enzyme solutions were directly added to 
the dry amylose powder. Because dry amylose absorbed a considerable volume 
of HjO (1 g amylose swelled to 12.7 mL) and the relatively large enzyme 
molecules were excluded from the resin, the enzyme solution was concentrated 
when added to the amylose resin. To account for this concentration effect, initial 
enzyme concentrations were multiplied by a factor of 1.28. The factor was 
calculated by measuring the volume of buffer (0.39 mL) that could be removed 
from the centrifuged cross-linked amylose with multiple intermediate 
centrifugation steps when 0.5 mL of phosphate buffer was added to 0.01 g dry 
amylose (0.5 mL/ 0.39 mL = 1.28). 
Enzyme solution (0.5 mL) of various concentrations was added to each tube 
containing starch or amylose. The suspensions were shaken on a rotary shaker 
(Labquake Instruments, Berkeley, CA) for 2.5 h to reach equilibrium and 
subsequently centrifuged at 13,600 x g for 2 min. An aliquot of 100 pL was 
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removed from each tube and was assayed for P-gal activity and protein 
concentration along with the samples before incubation. Activity or protein 
concentration values in the supernatant gave the free equilibrium concentrations. 
The amount of adsorbed enzyme at equilibrium was calculated from the 
differences between initial and free concentrations. 
Analytical Techniques 
Vertical 7.5% SDS-PAGE gels were run on a Bio-Rad Mini-Protean 11 gel 
apparatus by using the Laemmli buffer system (Laemmli 1970). The gels were 
silver-stained by the method of Wray et al. (1981). Whole cell samples were 
prepared by taking 0.1 mL of culture in an Eppendorf tube, centrifuging, 
removing supernatant and boiling the cell pellet in 0.1 mL SDS sample-treatment 
buffer. An equivalent of 5 pL of culture was loaded per lane of the gels. For 
Western blotting, SDS-PAGE gels were run as described, without staining, and the 
proteins transferred to a 0.2 pm nitrocellulose membrane using a Trans-Blot semi-
dry electrophoretic transfer system from Bio-Rad. The transfer was done for 24 
min at 10 V. After blocking the nitrocellulose membrane with 10 % milk-diluent, 
it was incubated overnight with the appropriate antibodies. The membrane was 
washed three times for 5 min with TBS buffer (Bio-Rad), and the proteins were 
detected by using gold-labeled Protein A. The bands were enhanced by a silver 
enhancement kit from Bio-Rad. 
p-Gal activity was measured by a modification of the method of Miller 
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(Miller 1972). Samples of enzyme solution (5-20 pL) were brought to 1 mL by the 
addition of Z-buffer (60 mM NazHPO^, 40 mM NaHgPO^, 10 mM KCl, 1 mM 
MgSO^, 50 mM P-mercaptoethanol, pH 7.0) in a microcuvette. The hydrolysis 
reaction was started with the addition of 0.2 mL of 4 mg/mL o-nitrophenyl 
P-D-galactopyranoside (ONPG). The solutions were mixed gently by inverting the 
cuvette several times, and then the rate of change of absorbance at 420 run 
(AA^zo/min, 1 cm light path) was measured with a Beckman DU-50 
spectrophotometer by using Beckman's Kinetics Soft-Pac module. The 
spectrophotometer cell was maintained at 28 °C. One unit of P-gal activity is 
defined as the amount of enzyme that hydrolyzes 1 nmol of ONPG per minute 
under the assay conditions. Protein concentrations was measured by Bio-Rad 
(Richmond, CA) standard/microassay. Electron microscopy (TEM) to visualize 
inclusion bodies was performed at the Iowa State University Microscopy Facility. 
RESULTS AND DISCUSSION 
Production and Purification of BSB119, BDE109 and WT-P-Gal 
The two fusion proteins, BSB119 and BDE109 (Figure 1), and wt-p-gal were 
produced in E. coli by expressing the plasmids pLC4, pBKDl and pUR291, 
respectively. Culture conditions were adjusted to minimize inclusion body 
formation or maximize the fraction of soluble product. However, the majority of 
the highly expressed fusion proteins and almost half of wt-P-gal produced were 
found in the cell-debris pellet, suggesting in vivo protein aggregation. Figure 3 
illustrates the expression and production of the two fusion proteins. Before EPTG 
induction, there was very little expression from the lac promoter, as can be seen 
by the absence of any major band at the expected molecular weight of the fusion 
proteins (Lane 1). After addition of IPTG to the culture, a large band at the 
expected molecular weights of the two fusion proteins appeared (Lane 2), 
indicating good production of the two proteins. The identities of the two fusion 
proteins were confirmed by Western blotting using monoclonal antibodies against 
P-gal (data not shown). Lanes 3 and 4 contain the cell-debris pellet and cell-free 
extract, respectively. Both fusion proteins were present mainly in the cell-debris 
fraction (Lane 3) and were barely visible in the soluble crude extract (Lane 4). 
However, P-gal activity was detectable in the crude extract and was concentrated 
by ammonium sulfate precipitation as described in Materials and Methods. Three 
different reagents (1 % Triton X-100, 0.1 % SOS, and 1 to 8 M urea) were used to 
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1  2 3 M 4 5 6 7 8  
1  2 3 M 4 5 6 7 8  
Figure 3. Production of BSB119 (a) and BDE109 (b). Lane M: molecular weight 
standards. Lane 1: whole cell extract before induction. Lane 2: whole 
cell extract after induction. Lane 3: cell-debris fraction. Lane 4; 
soluble crude extract. Lane 5: 2 M urea solubilized fraction. Lane 6: 
flow-through from the P-gal affinity column. Lane 7: eluted fusion 
protein. Lane 8: purified wt-P-gal 
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solubilize protein aggregates. Two molar urea gave the highest specific activity. 
Table 1 shows the amounts of P-gal activity extracted with 2 M urea from the cell-
debris fractions of cultures grown in seven different media. The urea solubilized 
fraction is shown in Lane 5. Lane 6 is the flow-through fraction from the P-gal 
affinity column and Lane 7 is the eluted fusion protein. WT-P-gal purified by a 
similar procedure after expression from the unmodified plasmid pUR291 is shown 
in Lane 8. 
Table 1. Effect of growth medium and 2 M urea extraction on the production 
of soluble BDE109 
Growth medium p-Gal activity (units/mL culture) 
Soluble extract Extracted with 2 M urea 
LB 202 739 
LB, 20 mM Tris-HCl, pH 7.0 165 816 
LB, 1 M sorbitol, 2.5 mM betaine 33 28 
LB, 0.6 M sucrose 27 82 
LB, 5 % glycerol 30 123 
Tryptone phosphate 346 706 
2YT 607 1101 
Inclusion body formation 
The presence of a major band corresponding to the expected molecular 
weights of the two fusion proteins in the cell-debris fraction led us to suspect 
inclusion body formation (Marston 1986). We confirmed the presence of inclusion 
bodies by comparing sections of E. coli cells, harboring the plasmids pUR291, 
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pLC4 and pBKDl, before and after induction with IPTG. Figure 4 shows the 
accumulation of such protein bodies in cells overexpressing the three proteins: 
wt-P-gal, BSB119 and BDE109. The dark, highly dense structures visible in the 
cytoplasm are the inclusion bodies. Although P-gal is a native E. coli protein, and 
as such is not expected to be recognized as "foreign" and aggregate in the cell, the 
observation is not unique. There have been previous reports of native proteins 
aggregating when cells were grown under stressful conditions (De Bemardez-
Clark and Georgiou 1991, Mitraki and King 1989, Gribskov and Burgess 1983). 
However, at least 50 % of the highly over-expressed P-gal was still present as 
soluble protein (data not shown), unlike the almost negligible amount of soluble 
fusion proteins. 
In general, a moderate increase of soluble enzyme was achieved when 
inducing cells with low concentration of IPTG (0.1 mM instead of 1 mM) and 
decreasing the growth temperature from 37 °C to 25 °C prior to induction. Schein 
and Notebom (1989) proposed the reduction of the growth temperature of bacteria 
as the easiest way to reduce inclusion body formation. Table 1 shows the effect of 
different growth media on the production of soluble BDE109. Since 2YT medium 
gave the highest amount of soluble enzyme, all cultures were grown in that 
medium. 
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Figure 4. TEM microscopy of sectioned E. coli (strain TGI) cells before (panels 
lA, HA, IDA) and after induction (panels IB, EE, DIB). The arrows 
indicate some of the protein aggregates or inclusion bodies. The 
magnification was 25000%. I: pUR291, H: pLC4, ID: pBKDl. The 
white bar represents 200 nm 
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Proteolytic degradation 
Another important aspect of recombinant protein expression is the possible 
degradation of the desired product by host proteases. Both BSB119 and BDE109 
were not significantly degraded when produced by inducible expression in E. coli. 
This is evidenced by the lack of any "ladders" in the purified fusion proteins 
(Figure 3, Lane 7). When BSB119 was produced by expression of the same 
plasmid pLC4 constitutively, significant in vivo degradation at the junction of 
P-gal and SBD was observed (Chen et al. 1991b, Dalmia and Nikolov 1994). We 
attribute this difference to the longer exposure of the fusion protein to host 
proteases as opposed to the relatively short exposure times in an inducible 
system. Many other approaches to overcome proteolytic degradation have been 
used. Use of protease deficient strains has been quite successful although lower 
productivities are observed (Ford et al. 1991). Use of protease inhibitors during 
and after cell lysis can also significantly reduce the exposure of the recombinant 
protein to active proteases. Genetic approaches, like changing the sequence of 
aminoacids at the junction of two domains, can also affect proteolytic degradation 
by altering putative protease recognition sites. 
Binding and Elution Studies on a Starch Column 
Table 2 shows the results of the starch binding and elution experiments for 
BSB119 and BDE109. The experimental approach was similar to the one used 
before (Dalmia and Nikolov 1994), but the fusion proteins used this time were 
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produced from inducible expression rather than constitutive. The results illustrate 
the similarities between the SBD and domain E and also some subtle differences. 
Both the fusion proteins bind very well to the starch column, but the percentage 
of unbound P-gal activity for BDE109 was about 17-19 % compared to only 4-5 % 
for BSB119. The unbound activity was not a result of saturating the starch 
column with protein because less than 0.1 mg of fusion protein was injected. Part 
of the BDE109 fusion protein was probably 'misfolded' in the domain E region 
leading to loss of starch-binding activity but retention of the P-gal activity. The 
loss of starch-binding activity in 4-5 % of BSB119 is explained by partial 
degradation of the fusion protein at the junction of P-gal and SBD since no intact 
fusion band was observed in the unbound fraction (Figure 5a, Lane 2). Our 
Table 2. Elution of BSB119 and BDE109 from starch with different 
oligosaccharides at pH 7.0 and 4 °C. Values for BDE109 are averages 
of two runs 
Eluant Bound Protein Eluted Protein 
(10 mM) (% of loaded) (% of bound) 
BSB119 BDE109 BSB119 BDE109 
Maltohexaose 96 82 61 51 
Maltoheptaose 95 81 73 59 
Maltodextrin (DP=10) 95 83 79 68 
a-cyclodextrin 95 82 66 63 
p-cyclodextrin 96 82 72 78 
y-cyclodextrin 96 82 65 72 
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earlier results (Dalmia and Nikolov 1994) are consistent with this observation, 
where we reported that approximately 40 % of the BSB119 did not bind to the 
starch column due to degradation of the fusion protein. The difference in the 
unbound amounts is due to greater level of degradation in the previously 
constitutively produced protein as opposed to that produced by induction. The 
loss of 17-19 % of starch-binding activity in BDE109 cannot be completely 
attributed to degradation, however. This is because of the presence of intact 
fusion protein in the unbound fraction of BDE109, as seen in Figure 5b, Lane 2 
and 2'. Lanes 1 in both gels (Figure 5a and 5b) contain the desalted crude extract 
that was loaded on the starch column. For BSB119, there is no noticeable intact 
fusion protein in Lane 2, while for BDE109 there is, indicating that part of the 
domain E is incorrectly folded or non-functional for some other reason. Lane 4 is 
the protein eluted from the starch column with 10 mM maltodextrin (DP=10). 
Elution of the two fusion proteins from the starch column was performed 
with various oligosaccharides as indicated in Table 2. All sugars acted as 
competitive ligands and eluted either fusion protein from starch, but with varying 
yields. For BSB119, the linear molecules maltoheptaose and maltodextrin (DP=10) 
were as good or better than P-cyclodextrin, which has been shown to have a high 
affinity for SBD (Williamson et al. 1992). For BDE109, the cyclic oligosaccharides 
were more efficient in eluting bound protein than the linear ones. Even 
maltodextrin with an average degree of polymerization of 10, and hence long 
enough to form a complete a-helical turn to mimic a cyclic molecule, was not as 
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Figure 5. Purification of BSB119 (a) and BDE109 (b) on starch. Lane M: 
molecular weight standards. Lane 1: desalted crude extract. Lane 2: 
unbound to starch column. Lane 3: wt-^-gal. Lane 4: eluted fusion 
protein. Lanes 2' and 4' are same as Lanes 2 and 4 but with twice 
the amount of protein 
efficient as p-cyclodextrin. 
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Adsorption Isotherms 
The adsorption isotherms for purified BSB119, BDE109 and wt-p-gal on 
starch and cross-linked amylose are shown in Figures 6 and 7, respectively. 
Isotherms for the two fusion proteins were of the high-affinity type, with very 
sharp initial slopes. The experimental data for the two fusion proteins were fitted 
with the Langmuir equation to calculate adsorption constants. The regression 
used was a non-linear least squares fit. WT-^-gal did not exhibit a high-affinity 
type isotherm, and the adsorbed amount increased linearly with increasing 
concentration of the enzyme in the bulk solution. The data for wt-|3-gal were 
fitted to a linear model. This behavior is similar to that reported by us for the 
adsorption of GA-I and GA-II on starch (Dalmia and Nikolov 1991). As before, to 
compare the binding of the fusion proteins with wt-p-gal we calculated initial 
slopes for the two types of isotherms. The iidtial slope of an adsorption isotherm 
is a measure of the affinity of the adsorbate for the adsorbent and could be 
considered as a Henry's law constant. Table 3 shows the calculated values of the 
adsorption constants: Kg, the association constant; Q^ax/ the maximum adsorption 
capacity; and a, the initial slope. The standard errors for the calculated 
parameters are also shown. 
Both fusion proteins have similar Kg values for starch, 0.39 x 10^ M'^ for 
BSB119 and 0.48 x 10® M'^ for BDE109. These values are about 10 times lower 
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Figure 6. Adsorption isotherms on raw starch. The lines are model fits 
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Figure 7. Adsorption isotherms on cross-linked amylose. The lines are model 
fits 
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Table 3. Adsorption constants calculated from the isotherms 
Qmax X 10-^ 
(mol/L resin) 
K, X 10" 
(L/mol) 
Initial slope 
(L/L resin) 
BSB119 
Starch 
Amylose 
85 ± 11(=) 
3.5 ± 0.2 
0.39 ± 0.1 
5.5 ± 1.2 
33 ± 2.9 
19 ± 3.5 
BDE109 
Starch 
Amylose 
42 ± 1.6 
3.7 ± 0.2 
0.48 ± 0.05 
2.8 ± 0.6 
20 ± 1.5 
10 ± 2.0 
WT-P-gal 
Starch 
Amylose 
— 
— 0.45 ± 0.03 
0.55 ± 0.03 
standard errors of the parameters 
than those reported for GA-I binding to starch (Dalmia and Nikolov 1991) and for 
CGTase binding to starch (Villette et al. 1992). Nevertheless, the values are still 
sufficiently high to conclude highly specific binding of the two fusion proteins on 
starch. The values on cross-linked amylose are also similar for the two fusion 
proteins and are about 10 times higher than the respective values on starch. The 
values on cross-linked amylose for the two fusion proteins are also similar. 
The biggest difference between the two fusion proteins comes when we compare 
their values on starch. BSB119, containing the SBD of GA-I, has double the 
capacity on raw starch compared to BDE109, which contains the domain E of 
CGTase. This big difference could be explained by examining the natural roles of 
GA-I and CGTase. GA-I is more naturally adapted to bind starch as it cleaves off 
glucose units from the non-reducing end of the starch molecule. Therefore, the 
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SBD in GA-I can bind to non-reducing ends of starch molecule as well as internal 
glucosyl residues in the starch molecule. However, domain E in CGTase possibly 
can bind to only the non-reducing ends of starch molecules and thereby exhibits 
lower binding capacity on raw starch than SBD. 
The initial slopes of both the fusion proteins are of the same order of 
magnitude for either starch or amylose and are about 50-100 times greater than 
the initial slopes for wt-P-gal. This indicates that the specific binding observed for 
the two fusion proteins on starch and amylose is a real effect of the affinity of the 
SBD and domain E. 
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CONCLUSIONS 
We have shown that the domain E of CGTase is an independent domain, 
which retains its starch-binding activity when separated from the other four 
domains in CGTase and attached to P-gal. In addition, comparison of the starch-
binding properties of domain E to SBD reveals that the two domains are very 
similar in function with slight differences in the structural features. SBD is more 
specific for the binding of linear oligosaccharides, while domain E shows higher 
specificity towards cyclic oligosaccharides. These results agree well with the 
strong sequence homology reported in the literature between the two domains. 
Either domain can be potentially utilized as an 'affinity tag' for simplifying the 
downstream recovery of fusion proteins. We have demonstrated a single-step 
purification of fusion proteins containing these domains, utilizing starch as an 
affinity adsorbent. The major disadvantage of SBD or domain E as affinity tags 
are the production of inclusion bodies when highly expressed in £. coli. To be 
able to utilize the starch-binding properties of SBD or domain E, the proteins 
containing them have to remain soluble. 
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GENERAL CONCLUSIONS 
The overall objective of this study was to evaluate the potential of a starch-
binding domain as an affinity tag combined with use of starch as an affinity 
adsorbent in the downstream recovery of fusion proteins. Two such starch-
binding domains were studied. The first domain was the SBD from 
glucoamylase-I of Aspergillus niger. We showed that a crude preparation of a 
P-gal fusion protein containing a 119 aminoacid segment from the C-terminus of 
GA-I from A. niger can be purified by a single-adsorption step using starch. The 
bound fusion protein could be effectively eluted from raw starch by using a 
variety of a-1,4 glucosyl oligosaccharides, which proved the specific nature of 
interactions between the SBD and starch. Mild elution conditions, wide selection 
of eluting ligands, and low cost of the starch adsorbent are features that make this 
system attractive for further process development. 
Another fusion protein was constructed containing glutathione S-transferase 
at the N-terminus and SBD at the C-terminus with a thrombin cleavage site 
between them. When expressed in E. coli, the fusion protein formed inclusion 
bodies, irrespective of the culture conditions employed. Various methods to 
reduce and/or eliminate inclusion body formation did not work. 
The second starch-binding domain studied was the domain E of CGTase. 
Domain E also interacts very specifically with starch as an independent domain, 
retaining its starch-binding activity when separated from the other four domains 
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in CGTase and attached to P-galactosidase. In addition, comparison of the starch-
binding properties of domain E to those of SBD revealed that the two domains are 
very similar in function with slight differences in the structural features. SBD is 
more specific for the binding of linear oligosaccharides, while domain E shows 
higher specificity towards cyclic oligosaccharides. These results agree well with 
the strong sequence homology reported in the literature between the two 
domains. 
Either domain could be utilized as an 'affinity tag' for simplifying the 
downstream recovery of fusion proteins. We have demonstrated a single-step 
purification of fusion proteins containing these domains, utilizing starch as an 
affinity adsorbent. The major disadvantage of SBD or domain E as affinity tags is 
that their fusions appear in inclusion bodies when highly expressed in E. coli. 
Inclusion bodies are insoluble in ordinary aqueous buffers and require the use of 
strong dénaturants for solubilization. In order to utilize starch as an affinity 
adsorbent for purification of fusion proteins, they should remain soluble and 
functional. Reagents used to solubilize inclusion bodies would also solubilize 
starch and hence prevent its use as an adsorbent. 
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